Senju Pharmaceutical focuses on developing and distributing a range of over-the-counter (OTC) products primarily aimed at addressing various eye-related issues. Their product lineup includes eye drops and solutions designed to alleviate symptoms such as dry eyes, redness, and discomfort caused by contact lenses. Notable products include "Mytear" series, which offers different formulations tailored for specific conditions like eyestrain, conjunctival hyperemia, and blepharitis. The company emphasizes the efficacy of its products, which are categorized based on their intended use and active ingredients, ensuring that consumers can find suitable solutions for their eye care needs.

In addition to their existing product offerings, Senju Pharmaceutical is actively engaged in innovation, as evidenced by recent launches and marketing approvals. The company has introduced new software for dry-eye analysis and has received marketing approval for products like "Mytear LUMIFY." This commitment to research and development highlights Senju's dedication to enhancing eye health through advanced therapeutic options. Their focus on OTC products allows for greater accessibility, enabling consumers to manage their eye health effectively without the need for prescriptions.

Japan

Senju Pharmaceutical utilized flexible thinking and a curious mindset to continuously develop new drugs primarily for the global field of ophthalmology. But the true "product" we strive for is happiness - the feeling that can be found with better eyesight. 

Senju Pharmaceutical

Company Details